These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial. van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402 [TBL] [Abstract][Full Text] [Related]
3. Doxycycline in early CJD: a double-blinded randomised phase II and observational study. Varges D; Manthey H; Heinemann U; Ponto C; Schmitz M; Schulz-Schaeffer WJ; Krasnianski A; Breithaupt M; Fincke F; Kramer K; Friede T; Zerr I J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):119-125. PubMed ID: 27807198 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275 [TBL] [Abstract][Full Text] [Related]
5. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial. de Yebenes JG; Landwehrmeyer B; Squitieri F; Reilmann R; Rosser A; Barker RA; Saft C; Magnet MK; Sword A; Rembratt A; Tedroff J; Lancet Neurol; 2011 Dec; 10(12):1049-57. PubMed ID: 22071279 [TBL] [Abstract][Full Text] [Related]